Effects of low-dose non-caloric sweetener consumption on gut microbiota in mice

Nutrients

Volumn 9, Issue 6, 2017, Pages

  Uebanso, Takashi ^a   Ohnishi, Ai ^a   Kitayama, Reiko ^a   Yoshimoto, Ayumi ^a   Nakahashi, Mutsumi ^a   Shimohata, Takaaki ^a   Mawatari, Kazuaki ^a   Takahashi, Akira ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Acceptable daily intake; Acesulfame K; Artificial sweetener; Bile acid; CE MS; Cholesterol; DGGE; Gut microbiota; Sucralose

Indexed keywords

ACESULFAME; BUTYRIC ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; GENOMIC DNA; MESSENGER RNA; RNA 16S; STEROID 12ALPHA MONOOXYGENASE; SUCRALOSE; ACETOSULFAME; BILE ACID; CHOLESTEROL; NONNUTRITIVE SWEETENER; SUCROSE; THIAZINE DERIVATIVE; TRIACYLGLYCEROL; TRICHLOROSUCROSE;

ANIMAL EXPERIMENT; ARTICLE; BACTEROIDES; BACTEROIDETES; BILE ACID METABOLISM; BODY WEIGHT; CAPILLARY ELECTROPHORESIS; CECUM; CHOLESTEROL LIVER LEVEL; CLOSTRIDIUM; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ELECTROSPRAY MASS SPECTROMETRY; ENERGY CONSUMPTION; FEMALE; FIRMICUTES; FOOD INTAKE; GENE EXPRESSION; INTESTINE FLORA; MALE; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME OF FLIGHT MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BODY WEIGHT GAIN; DIETARY REFERENCE INTAKE; DOSE RESPONSE; FECES; GASTROINTESTINAL TRACT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; CLOSTRIDIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; MALE; MICE; NON-NUTRITIVE SWEETENERS; RECOMMENDED DIETARY ALLOWANCES; SUCROSE; THIAZINES; TRIGLYCERIDES; WEIGHT GAIN;

EID: 85020307595     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9060662     Document Type: Article

References (39)

1. Gardner, C.; Wylie-Rosett, J.; Gidding, S.S.; Steffen, L.M.; Johnson, R.K.; Reader, D.; Lichtenstein, A.H. Nonnutritive sweeteners: Current use and health perspectives: A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2012, 35, 1798-1808, doi:10.2337/dc12-9002.
2. Fitch, C.; Keim, K.S. Position of the Academy of Nutrition and Dietetics: Use of nutritive and nonnutritive sweeteners. J. Acad. Nutr. Diet. 2012, 112, 739-758, doi:10.1016/j.jand.2012.03.009.
3. Swithers, S.E. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol. Metab. 2013, 24, 431-441, doi:10.1016/j.tem.2013.05.005.
4. Ministry of Health Labour and Welfare in Japan. Reports from the Japan National Health and Nutrition Survey. 2002 and 2015. Available online: http://www.mhlw.go.jp (accessed on 27 March 2017).
5. Pereira, M.A. Sugar-sweetened and artificially-sweetened beverages in relation to obesity risk. Adv. Nutr. 2014, 5, 797-808, doi:10.3945/an.114.007062.
6. Imamura, F.; O’Connor, L.; Ye, Z.; Mursu, J.; Hayashino, Y.; Bhupathiraju, S.N.; Forouhi, N.G. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: Systematic review, meta-analysis, and estimation of population attributable fraction. BMJ 2015, 351, h3576, doi:10.1136/bmj.h3576.
7. Cheungpasitporn, W.; Thongprayoon, C.; Edmonds, P.J.; Srivali, N.; Ungprasert, P.; Kittanamongkolchai, W.; Erickson, S.B. Sugar and artificially sweetened soda consumption linked to hypertension: A systematic review and meta-analysis. Clin. Exp. Hypertens. 2015, 37, 587-593, doi:10.3109/10641963.2015.1026044.
8. Kim, Y.; Je, Y. Prospective association of sugar-sweetened and artificially sweetened beverage intake with risk of hypertension. Arch. Cardiovasc. Dis. 2016, 109, 242-253, doi:10.1016/j.acvd.2015.10.005.
9. Cheungpasitporn, W.; Thongprayoon, C.; O’Corragain, O.A.; Edmonds, P.J.; Kittanamongkolchai, W.; Erickson, S.B. Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: A systematic review and meta-analysis. Nephrology (Carlton) 2014, 19, 791-797, doi:10.1111/nep.12343.
10. Suez, J.; Korem, T.; Zeevi, D.; Zilberman-Schapira, G.; Thaiss, C.A.; Maza, O.; Israeli, D.; Zmora, N.; Gilad, S.; Weinberger, A.; et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014, 514, 181-186, doi:10.1038/nature13793.
11. John, B.A.; Wood, S.G.; Hawkins, D.R. The pharmacokinetics and metabolism of sucralose in the mouse. Food Chem. Toxicol. 2000, 38 (Suppl. S2), 107-110, doi:10.1016/S0278-6915(00)00032-6.
12. Kidd, M.; Modlin, I.M.; Gustafsson, B.I.; Drozdov, I.; Hauso, O.; Pfragner, R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295, G260-G272, doi:10.1152/ajpgi.00056.2008.
13. Sikander, A.; Rana, S.V.; Prasad, K.K. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin. Chim. Acta 2009, 403, 47-55, doi:10.1016/j.cca.2009.01.028.
14. Abou-Donia, M.B.; El-Masry, E.M.; Abdel-Rahman, A.A.; McLendon, R.E.; Schiffman, S.S. Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J. Toxicol. Environ. Health A 2008, 71, 1415-1429, doi:10.1080/15287390802328630.
15. Wang, Q.P.; Lin, Y.Q.; Zhang, L.; Wilson, Y.A.; Oyston, L.J.; Cotterell, J.; Qi, Y.; Khuong, T.M.; Bakhshi, N.; Planchenault, Y.; et al. Sucralose Promotes Food Intake through NPY and a Neuronal Fasting Response. Cell Metab. 2016, 24, 75-90, doi:10.1016/j.cmet.2016.06.010.
16. Mattes, R.D.; Popkin, B.M. Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms. Am. J. Clin. Nutr. 2009, 89, 1-14, doi:10.3945/ajcn.2008.26792.
17. Uebanso, T.; Taketani, Y.; Fukaya, M.; Sato, K.; Takei, Y.; Sato, T.; Sawada, N.; Amo, K.; Harada, N.; Arai, H.; et al. Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E76-E84, doi:10.1152/ajpendo.00014.2009.
18. Li, M.; Gong, J.; Cottrill, M.; Yu, H.; de Lange, C.; Burton, J.; Topp, E. Evaluation of QIAamp DNA Stool Mini Kit for ecological studies of gut microbiota. J. Microbiol. Methods 2003, 54, 13-20, doi:10.1016/S0167-7012(02)00260-9.
19. Walter, J.; Tannock, G.W.; Tilsala-Timisjarvi, A.; Rodtong, S.; Loach, D.M.; Munro, K.; Alatossava, T. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl. Environ. Microbiol. 2000, 66, 297-303.
20. Hagio, M.; Matsumoto, M.; Fukushima, M.; Hara, H.; Ishizuka, S. Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. J. Lipid Res. 2009, 50, 173-180, doi:10.1194/jlr.D800041-JLR200.
21. Kami, K.; Fujimori, T.; Sato, H.; Sato, M.; Yamamoto, H.; Ohashi, Y.; Sugiyama, N.; Ishihama, Y.; Onozuka, H.; Ochiai, A.; et al. Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry. Metabolomics 2013, 9, 444-453, doi:10.1007/s11306-012-0452-2.
22. Ohashi, Y.; Hirayama, A.; Ishikawa, T.; Nakamura, S.; Shimizu, K.; Ueno, Y.; Tomita, M.; Soga, T. Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Mol. Biosyst. 2008, 4, 135-147, doi:10.1039/b714176a.
23. Ridlon, J.M.; Alves, J.M.; Hylemon, P.B.; Bajaj, J.S. Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship. Gut Microbes 2013, 4, 382-387, doi:10.4161/gmic.25723.
24. Evans, J.M.; Morris, L.S.; Marchesi, J.R. The gut microbiome: The role of a virtual organ in the endocrinology of the host. J. Endocrinol. 2013, 218, R37-R47, doi:10.1530/JOE-13-0131.
25. Cho, I.; Yamanishi, S.; Cox, L.; Methe, B.A.; Zavadil, J.; Li, K.; Gao, Z.; Mahana, D.; Raju, K.; Teitler, I.; et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488, 621-626, doi:10.1038/nature11400.
26. Cox, L.M.; Yamanishi, S.; Sohn, J.; Alekseyenko, A.V.; Leung, J.M.; Cho, I.; Kim, S.G.; Li, H.; Gao, Z.; Mahana, D.; et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014, 158, 705-721, doi:10.1016/j.cell.2014.05.052.
27. Kille, J.W.; Tesh, J.M.; McAnulty, P.A.; Ross, F.W.; Willoughby, C.R.; Bailey, G.P.; Wilby, O.K.; Tesh, S.A. Sucralose: Assessment of teratogenic potential in the rat and the rabbit. Food Chem. Toxicol. 2000, 38 (Suppl. S2), 43-52, doi:10.1016/S0278-6915(00)00027-2.
28. Sayin, S.I.; Wahlstrom, A.; Felin, J.; Jantti, S.; Marschall, H.U.; Bamberg, K.; Angelin, B.; Hyötyläinen, T.; Orešič, M.; Bäckhed, F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013, 17, 225-235, doi:10.1016/j.cmet.2013.01.003.
29. Ridlon, J.M.; Kang, D.J.; Hylemon, P.B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 2006, 47, 241-259, doi:10.1194/jlr.R500013-JLR200.
30. Reynier, M.O.; Montet, J.C.; Gerolami, A.; Marteau, C.; Crotte, C.; Montet, A.M.; Mathieu, S. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J. Lipid Res. 1981, 22, 467-473.
31. Atarashi, K.; Tanoue, T.; Shima, T.; Imaoka, A.; Kuwahara, T.; Momose, Y.; Cheng, G.; Yamasaki, S.; Saito, T.; Ohba, Y.; et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331, 337-341, doi:10.1126/science.1198469.
32. Vieira, A.T.; Teixeira, M.M.; Martins, F.S. The role of probiotics and prebiotics in inducing gut immunity. Front. Immunol. 2013, 4, 445, doi:10.3389/fimmu.2013.00445.
33. Fierer, N.; Jackson, J.A.; Vilgalys, R.; Jackson, R.B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl. Environ. Microbiol. 2005, 71, 4117-4120, doi:10.1128/AEM.71.7.4117-4120.2005.
34. Tannock, G.W.; Munro, K.; Harmsen, H.J.; Welling, G.W.; Smart, J.; Gopal, P.K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 2000, 66, 2578-2588.
35. Guo, X.; Xia, X.; Tang, R.; Zhou, J.; Zhao, H.; Wang, K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett. Appl. Microbiol. 2008, 47, 367-373, doi:10.1111/j.1472-765X.2008.02408.x.
36. Walter, J.; Hertel, C.; Tannock, G.W.; Lis, C.M.; Munro, K.; Hammes, W.P. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 2001, 67, 2578-2585, doi:10.1128/AEM.67.6.2578-2585.2001.
37. Matsuki, T.; Watanabe, K.; Fujimoto, J.; Takada, T.; Tanaka, R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 2004, 70, 7220-7228, doi:10.1128/AEM.70.12.7220-7228.2004.
38. Matsuki, T.; Watanabe, K.; Fujimoto, J.; Miyamoto, Y.; Takada, T.; Matsumoto, K.; Oyaizu, H.; Tanaka, R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 2002, 68, 5445-5451.
39. Layton, A.; McKay, L.; Williams, D.; Garrett, V.; Gentry, R.; Sayler, G. Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Appl. Environ. Microbiol. 2006, 72, 4214-4224, doi:10.1128/AEM.01036-05.